New strategy to protect bones during cancer treatment uses unique drug delivery system medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The following message was sent to members of the Department of Medicine from Dr. Kathleen Cooney, MD, MACP, chair of the Department of Medicine, and Nelson Chao, MD, MBA, chief of the Division of Hematologic Malignancies & Cellular Therapy.
Scientists and clinicians at the Duke University School of Medicine have discovered new details about how lung tissue heals after injury caused by toxins such as air pollution or cigarette smoke.
/PRNewswire/ NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the addition of two.
Dr Horwitz discusses the FDA approval of omidubicel in patients with blood cancers, key efficacy and safety data from the pivotal phase 3 trial, and the benefits omidubicel provides beyond improved neutrophil engraftment.